Orange Book product · Brand (NDA)
ZESTRIL
LISINOPRIL
At a glance
Apr 29, 1993
Approved
Brand (NDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 29, 1993
33 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
LISINOPRIL
Strength
2.5MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
NDA 019777
Product number
005
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2016QBRELISBrand (NDA)
NDA 208401 · AZURITY
- 1994PRINIVILBrand (NDA)
NDA 019558 · MERCK
- 2021LISINOPRILGeneric (ANDA)
ANDA 208920 · SCIEGEN PHARMS
- 2020LISINOPRILGeneric (ANDA)
ANDA 212041 · SCIEGEN PHARMS
- 2013LISINOPRILGeneric (ANDA)
ANDA 203508 · INVAGEN PHARMS
- 2013LISINOPRILGeneric (ANDA)
ANDA 202554 · ACCORD HLTHCARE
- 2007LISINOPRILGeneric (ANDA)
ANDA 078402 · WOCKHARDT BIO AG
- 2006LISINOPRILGeneric (ANDA)
ANDA 077622 · AUROBINDO
- 2005LISINOPRILGeneric (ANDA)
ANDA 077321 · LUPIN
- 2002LISINOPRILGeneric (ANDA)
ANDA 076102 · COREPHARMA
- 2002LISINOPRILGeneric (ANDA)
ANDA 075903 · ANNORA PHARMA
- 2002LISINOPRILGeneric (ANDA)
ANDA 075994 · CHARTWELL RX
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
